Physician profile
Sameh Arebi
NPI 1578695664
$1,291.14
in general payments reported to CMS, 2019-2025
10 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $115 · 2021: $260 · 2022: $312 · 2023: $170 · 2024: $146 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $627.59 | 2021-2025 | Blueprint Patient Specific Instrumentation, Gamma |
| Ferring Pharmaceuticals INC. | $277.29 | 2020-2023 | Euflexxa |
| Wright Medical Technology, INC. | $125.00 | 2019 | |
| Smith+Nephew, INC. | $121.28 | 2023 | Evos |
| Vertex Pharmaceuticals Incorporated | $41.30 | 2025 | |
| Ethicon US, LLC | $29.08 | 2019 | |
| Medartis INC. | $22.43 | 2024 | Aptus |
| Bioventus LLC | $22.42 | 2025 | Exogen Ultrasound Bone Healing System |
| Paragon 28, INC. | $13.79 | 2020 | |
| Orthofix Medical, INC. | $10.96 | 2025 | Accelstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Arebi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.